Table 1.
LV source | Sample size | Treatment cell dose | Post-treatment analyses | Post-treatment follow-up duration |
---|---|---|---|---|
CD68-ET3-LV (LTG1434) | 4—LV transduced | 106 | CBC | Up to 16 weeks |
FVIII activity | ||||
VCN | ||||
CD68-ET3-LV (pET68-3) | 7—Mock 16—Untreated 22—LV transduced |
106 | CBC | Up to 52 weeks |
FVIII activity | ||||
VCN | ||||
Chemistries (n = 13) |
LV, lentiviral vector; CBC, complete blood count; FVIII, factor VIII.